| review article | Q7318358 |
| scholarly article | Q13442814 |
| P50 | author | Altaf A Kondkar | Q90291918 |
| P2093 | author name string | Kakarla V Chalam | |
| Khaled K Abu-Amero | |||
| P2860 | cites work | The effect of resveratrol in experimental cataract model formed by sodium selenite | Q46962877 |
| Role of adenosine receptors in resveratrol-induced intraocular pressure lowering in rats with steroid-induced ocular hypertension. | Q48677149 | ||
| Pharmacokinetics of resveratrol metabolic profile in healthy humans after moderate consumption of red wine and grape extract tablets. | Q50504973 | ||
| Increased transport of resveratrol across monolayers of the human intestinal Caco-2 cells is mediated by inhibition and saturation of metabolites. | Q51934052 | ||
| Riluzole- and Resveratrol-Induced Delay of Retinal Ganglion Cell Death in an Experimental Model of Glaucoma. | Q53624330 | ||
| Diabetic Retinopathy | Q57232741 | ||
| Metabolites and tissue distribution of resveratrol in the pig | Q57759807 | ||
| Chemical Constituents of Polygonaceous Plants. I | Q61772400 | ||
| CHEMICAL CONSTITUENTS OF POLYGONACEOUS PLANTS. I. STUDIES ON THE COMPONENTS OF KO-J O-KON. (POLYGONUM CUSPIDATUM SIEB. ET ZUCC.) | Q76641876 | ||
| Resveratrol prevents endothelial nitric oxide synthase uncoupling and attenuates development of hypertension in spontaneously hypertensive rats | Q84271272 | ||
| Evaluation of the effects of resveratrol and bevacizumab on experimental corneal alkali burn | Q84869297 | ||
| Potent inhibitory effect of alpha-viniferin on human cytochrome P450 | Q87759946 | ||
| Endoplasmic reticulum stress in retinal vascular degeneration: protective role of resveratrol | Q95795941 | ||
| Pharmacokinetics, oral bioavailability, and metabolic profile of resveratrol and its dimethylether analog, pterostilbene, in rats | Q24597042 | ||
| Resveratrol ameliorates aging-related metabolic phenotypes by inhibiting cAMP phosphodiesterases | Q24608197 | ||
| Resveratrol and clinical trials: the crossroad from in vitro studies to human evidence | Q24618313 | ||
| Mechanisms of age-related macular degeneration | Q27000182 | ||
| A Molecular Mechanism for Direct Sirtuin Activation by Resveratrol | Q27675270 | ||
| Modulation of life-span by histone deacetylase genes in Saccharomyces cerevisiae. | Q27932078 | ||
| Small molecule activators of sirtuins extend Saccharomyces cerevisiae lifespan | Q28203572 | ||
| Mechanism of human SIRT1 activation by resveratrol | Q28238262 | ||
| A new class of phytoalexins from grapevines | Q28266831 | ||
| Resveratrol improves mitochondrial function and protects against metabolic disease by activating SIRT1 and PGC-1alpha | Q28274682 | ||
| Cancer chemopreventive activity of resveratrol, a natural product derived from grapes | Q28300555 | ||
| Resveratrol pretreatment protects rat brain from cerebral ischemic damage via a sirtuin 1-uncoupling protein 2 pathway | Q28570824 | ||
| Therapeutic potential of resveratrol: the in vivo evidence | Q29547413 | ||
| Transcriptional paradigms in mammalian mitochondrial biogenesis and function | Q29619590 | ||
| Review of recent data on the metabolism, biological effects, and toxicity of resveratrol in humans. | Q30641857 | ||
| Protection of injured retinal ganglion cell dendrites and unfolded protein response resolution after long-term dietary resveratrol | Q46591674 | ||
| Resveratrol attenuates thromboxane A2 receptor agonist-induced platelet activation by reducing phospholipase C activity | Q46740661 | ||
| Mitochondria as the primary target of resveratrol-induced apoptosis in human retinoblastoma cells | Q33255482 | ||
| Resveratrol regulates pathologic angiogenesis by a eukaryotic elongation factor-2 kinase-regulated pathway | Q33578980 | ||
| Small-molecule allosteric activators of sirtuins | Q33601236 | ||
| Selective synthesis and biological evaluation of sulfate-conjugated resveratrol metabolites. | Q34051374 | ||
| The role of oxidative stress in the pathogenesis of age-related macular degeneration. | Q34060719 | ||
| Resveratrol protects human lens epithelial cells against H2O2-induced oxidative stress by increasing catalase, SOD-1, and HO-1 expression | Q34079337 | ||
| Resveratrol modulates drug- and carcinogen-metabolizing enzymes in a healthy volunteer study | Q34103899 | ||
| Resveratrol prevents light-induced retinal degeneration via suppressing activator protein-1 activation | Q34162339 | ||
| Clinical pharmacology of resveratrol and its metabolites in colorectal cancer patients. | Q34168543 | ||
| Absorption of three wine-related polyphenols in three different matrices by healthy subjects | Q34173356 | ||
| SIRT1 is required for AMPK activation and the beneficial effects of resveratrol on mitochondrial function | Q34272924 | ||
| Repeat dose study of the cancer chemopreventive agent resveratrol in healthy volunteers: safety, pharmacokinetics, and effect on the insulin-like growth factor axis | Q34316229 | ||
| A reappraisal of the potential chemopreventive and chemotherapeutic properties of resveratrol | Q34318127 | ||
| Resveratrol based oral nutritional supplement produces long-term beneficial effects on structure and visual function in human patients | Q34411723 | ||
| Resveratrol, a polyphenolic phytoalexin present in red wine, enhances expression and activity of endothelial nitric oxide synthase. | Q34527448 | ||
| Role of resveratrol in prevention and therapy of cancer: preclinical and clinical studies. | Q34552323 | ||
| Flavonoids inhibit high glucose-induced up-regulation of ICAM-1 via the p38 MAPK pathway in human vein endothelial cells | Q34633637 | ||
| Antiplatelet activity of synthetic and natural resveratrol in red wine. | Q34719166 | ||
| Resveratrol stimulates mitochondrial bioenergetics to protect retinal pigment epithelial cells from oxidative damage | Q34979201 | ||
| The role of oxidative stress and antioxidants in the pathogenesis of age-related macular degeneration. | Q35028928 | ||
| The pathophysiology and treatment of glaucoma: a review | Q35168230 | ||
| Phase I randomized, double-blind pilot study of micronized resveratrol (SRT501) in patients with hepatic metastases--safety, pharmacokinetics, and pharmacodynamics | Q35215147 | ||
| Subchronic oral toxicity and cardiovascular safety pharmacology studies of resveratrol, a naturally occurring polyphenol with cancer preventive activity | Q35570811 | ||
| Resveratrol stimulates AMP kinase activity in neurons | Q35758555 | ||
| Nutritional modulation of age-related macular degeneration. | Q36083941 | ||
| Resveratrol as an anti-inflammatory and anti-aging agent: mechanisms and clinical implications | Q36098986 | ||
| Resveratrol mitigates rat retinal ischemic injury: the roles of matrix metalloproteinase-9, inducible nitric oxide, and heme oxygenase-1. | Q36554020 | ||
| Resveratrol inhibits uveal melanoma tumor growth via early mitochondrial dysfunction | Q36769189 | ||
| Vasoprotective effects of resveratrol and SIRT1: attenuation of cigarette smoke-induced oxidative stress and proinflammatory phenotypic alterations | Q36906571 | ||
| Observation of human retinal remodeling in octogenarians with a resveratrol based nutritional supplement | Q37050815 | ||
| Resveratrol prevents antibody-induced apoptotic death of retinal cells through upregulation of Sirt1 and Ku70 | Q37078409 | ||
| Phytochemicals and age-related eye diseases | Q37230509 | ||
| The role of steroids in outflow resistance | Q37314663 | ||
| Wine, resveratrol and health: a review. | Q37483833 | ||
| Resveratrol Suppresses Expression of VEGF by Human Retinal Pigment Epithelial Cells: Potential Nutraceutical for Age-related Macular Degeneration | Q37665378 | ||
| Resveratrol oligomers for the prevention and treatment of cancers | Q37706275 | ||
| Moderate red wine consumption and cardiovascular disease risk: beyond the "French paradox". | Q37730774 | ||
| Regulation of SIRT1 in cellular functions: role of polyphenols | Q37745178 | ||
| Bioavailability of resveratrol | Q37831925 | ||
| Resveratrol: a cardioprotective substance | Q37831926 | ||
| Transport, stability, and biological activity of resveratrol | Q37831931 | ||
| Neuroprotective properties of resveratrol and derivatives | Q37831938 | ||
| Regulation of PGC-1α, a nodal regulator of mitochondrial biogenesis | Q37834857 | ||
| Mammalian Sirt1: insights on its biological functions | Q37872821 | ||
| Age related macular degeneration and drusen: neuroinflammation in the retina | Q37899331 | ||
| Administration of resveratrol: What formulation solutions to bioavailability limitations? | Q37943051 | ||
| Anti-VEGF Treatment Strategies for Wet AMD. | Q38004494 | ||
| Enhancing the delivery of resveratrol in humans: if low bioavailability is the problem, what is the solution? | Q38262965 | ||
| Resveratrol nanoformulations: challenges and opportunities | Q38311975 | ||
| Oxidative stress, mitochondrial damage and diabetic retinopathy | Q38561778 | ||
| Retinal ganglion cell apoptotic pathway in glaucoma: Initiating and downstream mechanisms | Q38615499 | ||
| Mitochondrial DNA has a pro-inflammatory role in AMD. | Q38841002 | ||
| Resveratrol induces apoptosis associated with mitochondrial dysfunction in bladder carcinoma cells | Q39346159 | ||
| Transgenic expression and activation of PGC-1α protect dopaminergic neurons in the MPTP mouse model of Parkinson's disease | Q39460847 | ||
| trans-resveratrol inhibits hyperglycemia-induced inflammation and connexin downregulation in retinal pigment epithelial cells | Q39688331 | ||
| Retinal protective effects of resveratrol via modulation of nitric oxide synthase on oxygen-induced retinopathy | Q39938019 | ||
| Metabolism of resveratrol in breast cancer cell lines: impact of sulfotransferase 1A1 expression on cell growth inhibition. | Q40035042 | ||
| Resveratrol reduces oxidation and proliferation of human retinal pigment epithelial cells via extracellular signal-regulated kinase inhibition. | Q40460919 | ||
| Human hepatic cell uptake of resveratrol: involvement of both passive diffusion and carrier-mediated process | Q40573697 | ||
| Towards ensuring the safety of vitamins and minerals | Q40711143 | ||
| Characterization of two genes required for the position-effect control of yeast mating-type genes | Q41585209 | ||
| Resveratrol prevents the expression of glaucoma markers induced by chronic oxidative stress in trabecular meshwork cells | Q42058434 | ||
| Antioxidant effect of trans-resveratrol in cultured human retinal pigment epithelial cells. | Q42489796 | ||
| Resveratrol Targeting of Carcinogen-Induced Brain Endothelial Cell Inflammation Biomarkers MMP-9 and COX-2 is Sirt1-Independent | Q42540745 | ||
| Resveratrol improves diabetic retinopathy possibly through oxidative stress - nuclear factor κB - apoptosis pathway | Q42712946 | ||
| Resveratrol reverses endothelial nitric-oxide synthase uncoupling in apolipoprotein E knockout mice. | Q42976945 | ||
| Steady-State pharmacokinetics and tolerability of trans-resveratrol 2000 mg twice daily with food, quercetin and alcohol (ethanol) in healthy human subjects. | Q43042961 | ||
| Involvement of breast cancer resistance protein (BCRP1/ABCG2) in the bioavailability and tissue distribution of trans-resveratrol in knockout mice | Q43128084 | ||
| Pharmacokinetics of trans-resveratrol following repeated administration in healthy elderly and young subjects | Q43268376 | ||
| Resveratrol prevents hyperglycemia-induced endothelial dysfunction via activation of adenosine monophosphate-activated protein kinase | Q43295623 | ||
| Resveratrol blocks diabetes-induced early vascular lesions and vascular endothelial growth factor induction in mouse retinas | Q43442634 | ||
| Inhibition of CYP3A, CYP1A and CYP2E1 activities by resveratrol and other non volatile red wine components | Q43794224 | ||
| Activation and role of MAP kinase-dependent pathways in retinal pigment epithelial cells: ERK and RPE cell proliferation | Q44119145 | ||
| In vivo and in vitro metabolism of trans-resveratrol by human gut microbiota. | Q44737175 | ||
| Are linear regression techniques appropriate for analysis when the dependent (outcome) variable is not normally distributed? | Q45179675 | ||
| Prevention of ocular inflammation in endotoxin-induced uveitis with resveratrol by inhibiting oxidative damage and nuclear factor-kappaB activation | Q46091698 | ||
| Chemopreventive potential of resveratrol in mouse skin tumors through regulation of mitochondrial and PI3K/AKT signaling pathways | Q46367720 | ||
| P275 | copyright license | Creative Commons Attribution | Q6905323 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 4 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | stilbenoid | Q526360 |
| eye disease | Q3041498 | ||
| hydrocarbon | Q43648 | ||
| P5008 | on focus list of Wikimedia project | ScienceSource | Q55439927 |
| P304 | page(s) | 200 | |
| P577 | publication date | 2016-04-05 | |
| P1433 | published in | Nutrients | Q7070485 |
| P1476 | title | Resveratrol and Ophthalmic Diseases | |
| P478 | volume | 8 |
| Q61814894 | -Allylmercapro--Acetylcysteine Attenuates the Oxidation-Induced Lens Opacification and Retinal Pigment Epithelial Cell Death In Vitro |
| Q50087449 | A comprehensive review of the health perspectives of resveratrol. |
| Q47711211 | Distribution and accumulation of dietary ergothioneine and its metabolites in mouse tissues. |
| Q91993706 | Effect of Resveratrol on In Vitro and In Vivo Models of Diabetic Retinophathy: A Systematic Review |
| Q57030415 | Effect of Resveratrol, a Dietary-Derived Polyphenol, on the Oxidative Stress and Polyol Pathway in the Lens of Rats with Streptozotocin-Induced Diabetes |
| Q91740320 | Effects of Resveratrol on Inflammatory Biomarkers in Glaucomatous Human Trabecular Meshwork Cells |
| Q55492700 | Fatty Acids Dietary Supplements Exert Anti-Inflammatory Action and Limit Ganglion Cell Degeneration in the Retina of the EAE Mouse Model of Multiple Sclerosis. |
| Q89477374 | Fruits |
| Q57297134 | Further Evidence on Efficacy of Diet Supplementation with Fatty Acids in Ocular Pathologies: Insights from the EAE Model of Optic Neuritis |
| Q64229464 | Health Benefits of Polyphenols and Carotenoids in Age-Related Eye Diseases |
| Q36256811 | Improving key enzyme activity in phenylpropanoid pathway with a designed biosensor |
| Q61813444 | Nanostructured Chitosan-Based Biomaterials for Sustained and Colon-Specific Resveratrol Release |
| Q38664371 | Neuroprotection by (endo)cannabinoids in glaucoma and retinal neurodegenerative diseases. |
| Q91790934 | Oxidative Stress and Microvascular Alterations in Diabetic Retinopathy: Future Therapies |
| Q90070032 | Oxidative Stress as the Main Target in Diabetic Retinopathy Pathophysiology |
| Q46248374 | Oxidative stress and reactive oxygen species: a review of their role in ocular disease |
| Q46246399 | Resveratrol Prevents ROS-Induced Apoptosis in High Glucose-Treated Retinal Capillary Endothelial Cells via the Activation of AMPK/Sirt1/PGC-1α Pathway. |
| Q89509277 | Resveratrol as Inducer of Autophagy, Pro-Survival, and Anti-Inflammatory Stimuli in Cultured Human RPE Cells |
| Q37590386 | Resveratrol inhibits transforming growth factor-β2-induced epithelial-to-mesenchymal transition in human retinal pigment epithelial cells by suppressing the Smad pathway |
| Q42363696 | Resveratrol reverses the adverse effects of bevacizumab on cultured ARPE-19 cells. |
| Q90231591 | Resveratrol: A miraculous natural compound for diseases treatment |
| Q38618547 | Significance of Resveratrol in Clinical Management of Chronic Diseases. |
| Q37734472 | Tissue Distribution of trans-Resveratrol and Its Metabolites after Oral Administration in Human Eyes. |
| Q91714489 | Treatment with, Resveratrol, a SIRT1 Activator, Prevents Zearalenone-Induced Lactic Acid Metabolism Disorder in Rat Sertoli Cells |
| Q57812760 | Use of Nutraceuticals in Angiogenesis-Dependent Disorders |
Search more.